Multicenter retrospective study of efficacy of the combination of cetuximab and paclitaxel in patients with recurrent and/or metastatic oral squamous cell carcinoma
Not Applicable
Recruiting
- Conditions
- Recurrent and/or metastatic oral squamous cell carcinoma
- Registration Number
- JPRN-UMIN000029351
- Lead Sponsor
- agasaki university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. Before December 2012 there is a treatment history with Cetuximab. 2. Besides oral cancer, it has serious complications affecting life prognosis 3. Other patients whose research managers judged inappropriate as subjects.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method